Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 0.64 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 2.2 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 1 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 2.0 | BCD100624C013 | 1.12 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 1.16 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 1.4 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 1.83 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 1.81 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 0.0 | BCD100624C001 | 3.88 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 0.5 | BCD100624C003 | 1.99 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 1.0 | BCD100624C007 | 3.21 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 2.0 | BCD100624C011 | 2.11 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 4.0 | BCD100624C015 | 1.37 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 8.0 | BCD100624C019 | 2.63 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 12.0 | BCD100624C023 | 1.84 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | C | 24.0 | BCD100624C027 | 1.24 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 2.47 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | 1.25 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 1.81 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 1.51 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 3.11 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 2.01 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 1.23 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol | 0.5 | BCD100624C004 | 1.13 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol | 1.0 | BCD100624C008 | 1.82 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol | 2.0 | BCD100624C012 | 0.91 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol | 4.0 | BCD100624C016 | 1.66 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol | 8.0 | BCD100624C020 | 1.21 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol | 12.0 | BCD100624C024 | 1.56 | pmol/sample |
| LMFA01030092 | cis-selacholeic acid | 25OH-Chol | 24.0 | BCD100624C028 | 2.96 | pmol/sample |